Assessment of Atherogenic Indices after treating with Sookshma Eladi Churnam in Hyperlipidaemia - A Case Study
Background: Hyperlipidaemia is one of the most important conditions to cause atherosclerosis. Atherosclerosis is a major risk factor for coronary artery disease (CAD). CAD has become the epidemic of modern civilization in which Hyperlipidaemia predominantly contributes to its pathogenesis. There are certain atherogenic ratios that are strongly predictive of CAD. Three important atherogenic ratios are Atherogenic Index of Plasma (AIP), Castelli’s Risk Index I & II (CRI-I &CRI-II). We studied the significance of these atherogenic ratios in a case study having hyperlipidaemia by giving Ayurvedic drug Sookshma eladi choornam. Methods: A 53-year-old patient presented with tiredness, shortness of breath on exertion, heaviness of the body parts for the past 4 months. Management was done on OPD based treatment. The patient was administered 3 grams of Sookshma eladi choornam orally with go ghrita as anupana. Result: There was a marked reduction in symptoms like tiredness, heaviness and shortness of breath with three months of treatment. The lipid values after three months of treatment and follow up of one month showed a marked reduction in TC(Total Cholesterol), TG(Triglyceride), LDL-C(Low density lipoprotein – Cholesterol) and increase in HDL(High density lipoprotein – Cholesterol). Conclusion: Significant result was observed in both subjective symptoms and in objective parameters after administering Sookshma eladi choornam.
Copyright (c) 2021 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.